Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial

Jordana B. Cohen, Thomas C. Hanff, Preethi William, Nancy Sweitzer, Nelson R. Rosado-Santander, Carola Medina, Juan E. Rodriguez-Mori, Nicolás Renna, Tara I. Chang, Vicente Corrales-Medina, Jaime F. Andrade-Villanueva, Alejandro Barbagelata, Roberto Cristodulo-Cortez, Omar A. Díaz-Cucho, Jonas Spaak, Carlos E. Alfonso, Renzo Valdivia-Vega, Mirko Villavicencio-Carranza, Ricardo J. Ayala-García, Carlos A. Castro-CallirgosLuz A. González-Hernández, Eduardo F. Bernales-Salas, Johanna C. Coacalla-Guerra, Cynthia D. Salinas-Herrera, Liliana Nicolosi, Mauro Basconcel, James B. Byrd, Tiffany Sharkoski, Luis E. Bendezú-Huasasquiche, Jesse Chittams, Daniel L. Edmonston, Charles R. Vasquez, Julio A. Chirinos

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint Dive into the research topics of 'Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial'. Together they form a unique fingerprint.

Medicine & Life Sciences